|
385 Clarke says Society
will be part of professional body The Royal Pharmaceutical Society should form an integral part of the future professional body for pharmacy, Nigel Clarke’s inquiry on the matter has concluded
PJ 2008;280:385
Full Text
385 NHS Wales consultation proposes
abolition of internal market NHS trusts
and local health boards in Wales are to receive funding directly from
ministers or from a newly created national board, abolishing the internal
market in NHS Wales
PJ 2008;280:385
Full Text
385 White Paper to offer new pharmacy roles Plans
to extend the services available from community pharmacies in England were due
to be published in a White Paper this week after The Journal went to press. A
link to the document will be posted on PJ Online as soon as it becomes available
PJ 2008;280:385
Full Text
386 Adverse reactions to paediatric
medicines studied A new community pharmacy-based
system to identify paediatric adverse drug reactions (ADRs) is being piloted
in Scotland
PJ 2008;280:386
Full Text
386 NPA and PCA to support MUR evaluations Plans to support pharmacists to undertake medicines use reviews and evaluate their success have been hatched by the National Pharmacy Association and the Primary Care Pharmacists’ Association
PJ 2008;280:386
Full Text
386 NICE to assess cetuximab Assessment of cetuximab for colorectal and head and neck cancer will form part of the National Institute for Health and Clinical Excellence’s 16th wave of technology appraisals
PJ 2008;280:386
Full Text
386 All GP computer systems in Wales should
now have necessary repeat dispensing software All
GP computer systems in Wales should now have the necessary software for repeat
dispensing, according to Paul Gimson, chief executive of Community Pharmacy Wales
PJ 2008;280:386
Full Text
387 Vascular checks could
be done through pharmacies Community pharmacy could play a leading role in delivering the Government’s national vascular screening programme for England, unveiled this week by health secretary Alan Johnson
PJ 2008;280:387
Full Text
387 Naproxen for period pain now OTC medicine Naproxen
is now available over the counter to treat period pain following approval of
its switch from prescription-only status by the Medicines and Healthcare products
Regulatory Agency
PJ 2008;280:387
Full Text
387 Pharmacists could improve access for drug
misusers Pharmacist prescribing could be used to
improve access to treatments for drug misuse, according to a report published
by the Scottish Government
PJ 2008;280:387
Full Text
388 Telmisartan effective
alternative to ACE inhibitor Telmisartan, an angiotensin
II receptor blocker, is an effective alternative treatment to the angiotensin-converting
enzyme inhibitor ramipril in preventing cardiovascular events and has fewer side
effects, according to data from a study presented at the annual scientific meeting
of the American College of Cardiology in Chicago this week. However, combining
the two drugs did not produce any additional benefits and was associated with
more adverse events
PJ 2008;280:388
Full Text
388 Atherosclerosis not slowed by adding ezetimibe
to simvastatin Clinicians treating patients with high cholesterol should return to statins first line — this was the message from a panel of experts at the American College of Cardiology annual scientific session held in Chicago this week
PJ 2008;280:388
Full Text
388 Mixed results for BP with weight loss drugs In
patients with hypertension, dietary intervention or use of orlistat reduces both
body weight and blood pressure, a meta-analysis reveals
PJ 2008;280:388
Full Text
389 Abacavir and didanosine
linked to heart attack risk in HIV patients An
unexpected increased risk of myocardial infarction (MI) in HIV patients recently
exposed to abacavir and didanosine has been revealed in a study published online
PJ 2008;280:389
Full Text
389 Heparin batches recalled in four European
countries Batches of heparin products have been
recalled from sale in four European countries
PJ 2008;280:389
Full Text
389 Astellas asks pharmacists to check tacrolimus
brand Pharmacists should check that they dispense
the correct brand of tacrolimus for transplant patients following several reports
of potentially serious dispensing errors involving Prograf and Advagraf. Patients
should be maintained on the same brand unless a change is instigated by their
transplant specialist
PJ 2008;280:389
Full Text
389 FDA looks at possible increased stroke risk
with tiotropium A possible increased risk of stroke
in patients using tiotropium is being investigated by the US Food and Drug Administration
PJ 2008;280:389
Full Text
390 MPs slate plans to cut
funding for second degrees Government proposals
to cut funding for graduates who want to retrain as pharmacists have been dealt
a blow after investigation by a Parliamentary committee
PJ 2008;280:390
Full Text
390 New focus for health promotion in hospitals Health
promotion is to be given a new priority in hospitals in Scotland, with NHS boards
being told to implement health improvement programmes
PJ 2008;280:390
Full Text
390 New Manchester centre to move research into
practice Creation of a new biomedical research
centre in Manchester that will drive the translation of medical research into
clinical practice has been announced by the Department of Health
PJ 2008;280:390
Full Text
390 Prescribing of treatments for obesity increases
in Scotland Use of drugs to treat obesity has increased dramatically in Scotland, according to new NHS statistics. Prescriptions for orlistat grew by 14.9 per cent in 2006–07 compared with the previous year and prescriptions for sibutramine grew by 9.4 per cent
PJ 2008;280:390
Full Text
390 2008 flu immunisation plans Details of this year’s influenza immunisation campaign for England have been announced by the Department of Health
PJ 2008;280:390
Full Text
391 Pharmacy companies now
liable to prosecution for manslaughter Pharmacy
companies are now liable to prosecution for corporate manslaughter under new
legislation that comes into effect from 6 April 2008
PJ 2008;280:391
Full Text
391 Consider hand delivery of paper script returns Community
pharmacists in England should consider hand-delivering their monthly paper prescription
returns to reduce the risk of confidential patient data going missing, according
to guidance from the Pharmaceutical Services Negotiating Committee
PJ 2008;280:391
Full Text
391 Most GPs in Wales oppose free NHS prescriptions Most
GPs in Wales think that NHS prescriptions should not be free of charge to the
user, according to a Liberal Democrat survey launched on the first anniversary
of the removal of prescription charges
PJ 2008;280:391
Full Text
391 Pharmacy application fees Fees of up to £3,000 for applications to primary care trusts in England for pharmacy contracts have been welcomed by the Pharmaceutical Services Negotiating Committee
PJ 2008;280:391
Full Text
391 Posters show Welsh NHS priorities Posters setting out the Welsh Assembly Government’s priorities for the NHS are to be displayed across Wales, health minister Edwina Hart announced last week
PJ 2008;280:391
Full Text
392 Tocilizumab effective
for arthritis Evidence to support the effectiveness of tocilizumab — the first humanised interleukin-6-receptor monoclonal antibody — in patients with rheumatoid arthritis has been published
PJ 2008;280:392
Full Text
392 New genetic links found for lung cancer Further
genetic links for lung cancer have been identified in a series of large genome-wide
association studies
PJ 2008;280:392
Full Text
392 Starvation protects mice against chemotherapy
toxicity Short-term starvation provides protection
against the adverse effects of high-dose chemotherapy in mice, a study published
on-line suggests
PJ 2008;280:392
Full Text
392 CF protein identified A
key regulator of inflammation and infection in the disease process of people
with cystic fibrosis (CF) has been identified, paving the way for new treatment
strategies
PJ 2008;280:392
Full Text
392 Breast cancer vaccine Established
breast tumours in mice were no longer detectable after treatment with a vaccine
expressing an HER-2 antigen in a recent study
PJ 2008;280:392
Full Text
392 Cancer trial success rates Between
a quarter and a half of new cancer treatments assessed in publicly funded clinical
trials become successful new interventions, according to an analysis of all publicly
funded phase III cancer therapy trials conducted in the US between 1955 and 2000
PJ 2008;280:392
Full Text
392 New avenue for eye treatments New
treatments for vascular eye diseases, such as age-related macular degeneration
and diabetic retinopathy, could target a protein involved in stabilising retinal
vasculature, according to new research published online
PJ 2008;280:392
Full Text |
The
Pharmaceutical Journal